-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Neutral on RXO, Raises Price Target to $20

Benzinga·07/16/2026 17:31:49
语音播报
Goldman Sachs analyst Jordan Alliger maintains RXO (NYSE:RXO) with a Neutral and raises the price target from $18 to $20.